Through the detection and study of the common SNP rs2228226 in GLI1 and ARHGAP9, we explored its associations with recurrence, metastasis, death, and chemotherapy sensitivity after pT4a GAC, aiming to identify SNPs as potential biomarkers and effective therapeutic targets for prolonging survival in advanced GC patients. The gene discussed is ARHGAP9; the disease is gastric cancer.